...
首页> 外文期刊>Kidney international. >Puromycin aminonucleoside metabolism by glomeruli and glomerular epithelial cells in vitro
【24h】

Puromycin aminonucleoside metabolism by glomeruli and glomerular epithelial cells in vitro

机译:嘌呤霉素氨基核苷经肾小球和肾小球上皮细胞代谢

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Puromycin aminonucleoside metabolism by glomeruli and glomerular epithelial cells in vitro. Two puromycin aminonucleoside (PAN) excretion products were purified by HPLC from urine of PAN-treated rats and characterized by nuclear magnetic resonance as N6-dimethyl-3'amino-3'deoxyadenosine (DA-Ado) and N6-methyl-3'amino-3'deoxy-adenosine (MA-Ado), respectively, the former corresponding to unmodified PAN. DA-Ado was not a substrate for adenosine deaminase (ADA), purine nucleoside phosphorylase (PNP) or xanthine oxidase (XO), while MA-Ado was consecutively converted into hypoxanthine by a mixture of ADA and PNP. A different rate of transformation of DA-Ado and MA-Ado into hypoxanthine by isolated glomeruli was observed and was higher for the monomethylated analogue by a factor of 3 (79% vs. 21%); this was ascribed to the rate-limiting level of a demethylase activity acting on DA-Ado. Furthermore, DA-Ado was not transformed by glomerular epithelial cells in culture, while a little amount of MA-Ado was converted into hypoxanthine after six hours of incubation. In spite of this different metabolic behavior, the same order of cytotoxicity on glomerular epithelial cells in culture was observed for MA-Ado, DA-Ado and commercial PAN. All these molecules induced a dose response inhibition of [3H]thymidine incorporation into DNA after exposure for two hours and a marked alteration of cell viability which was not inhibited by free radical scavengers and deferoxamine. This study provides the first evidence for a glomerular metabolism of PAN and its urinary metabolite MA-Ado involving their transformation via the purine cycle enzymes. The rate of glomerular transformation of PAN in isolated glomeruli and the lack of its metabolism in cultured epithelial cells implies the presence of demethylase enzymes within the glomerulus and their absence in cultured epithelial cells. However, the similar cytotoxic effect of PAN and MA-Ado on cultured epithelial cells supports the concept that a mechanism which does not involve the purine cycle is responsible for PAN glomerular toxicity in vitro.
机译:嘌呤霉素氨基核苷在体外被肾小球和肾小球上皮细胞代谢。通过HPLC从PAN处理的大鼠尿液中纯化了两种嘌呤霉素氨基核苷(PAN)排泄产物,并通过核磁共振将其表征为N6-二甲基-3'氨基-3'脱氧腺苷(DA-Ado)和N6-甲基-3'氨基-3'脱氧腺苷(MA-Ado)分别对应于未修饰的PAN。 DA-Ado不是腺苷脱氨酶(ADA),嘌呤核苷磷酸化酶(PNP)或黄嘌呤氧化酶(XO)的底物,而MA-Ado被ADA和PNP的混合物连续转化为次黄嘌呤。观察到分离的肾小球将DA-Ado和MA-Ado转化为次黄嘌呤的速率不同,单甲基化类似物的转化率更高,为3倍(79%vs. 21%)。这归因于作用于DA-Ado的脱甲基酶活性的限速水平。此外,在培养六小时后,DA-Ado未被肾小球上皮细胞转化,而少量的MA-Ado被转化为次黄嘌呤。尽管有这种不同的代谢行为,但对于MA-Ado,DA-Ado和市售PAN,在培养中的肾小球上皮细胞上观察到相同程度的细胞毒性。所有这些分子在暴露2小时后均诱导了对[3H]胸苷掺入DNA的剂量反应抑制,并显着改变了细胞活力,而自由基清除剂和去铁胺并没有抑制这种活力。这项研究为PAN及其尿代谢产物MA-Ado的肾小球代谢提供了第一个证据,涉及其通过嘌呤循环酶的转化。分离的肾小球中PAN的肾小球转化速率及其在培养的上皮细胞中缺乏新陈代谢意味着肾小球内存在脱甲基酶,而在培养的上皮细胞中则缺乏脱甲基酶。然而,PAN和MA-Ado对培养的上皮细胞的类似细胞毒性作用支持这样的概念,即不涉及嘌呤循环的机制是体外PAN肾小球毒性的原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号